Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment

References

• Maruthur NM The growing prevalence of type 2 diabetes: increased incidence or improved survival? Curr Diab Rep 2013 13 6 786 794 24072478
   PubMed Web of Science ®Google Scholar
• World Health Organization Geneva: Global status report on noncommunicable diseases 2010 Available from:http://www.who.int/nmh/publications/ncd_report_full_en.pdf Accessed July 24, 2014
   Google Scholar
• Nowlin SY Hammer MJ D’Eramo Melkus G Diet, inflammation, and glycemic control in type 2 diabetes: an integrative review of the literature J Nutr Metab 2012 2012 542698 23316349
   PubMedGoogle Scholar
• Kempf K Rose B Herder C Kleophas U Martin S Kolb H Inflammation in metabolic syndrome and type 2 diabetes: impact of dietary glucose Ann N Y Acad Sci 2006 1084 30 48 17151291
   PubMed Web of Science ®Google Scholar
• Navarro-Gonzalez J Mora-Fernandez C Gomez-Chinchon M Muros M Herrera H Garcia J Serum and gene expression profile of tumor necrosis factor-alpha and interleukin-6 in hypertensive diabetic patients: effect of amlodipine administration Int J Immunopathol Pharmacol 2010 23 1 51 59 20377994
   PubMed Web of Science ®Google Scholar
• Mann S Beedie C Balducci S Changes in insulin sensitivity in response to different modalities of exercise: a review of the evidence Diabetes Metab Res Rev 2014 30 4 257 268 24130081
   PubMed Web of Science ®Google Scholar
• Kolb H Mandrup-Poulsen T An immune origin of type 2 diabetes? Diabetologia 2005 48 6 1038 1050 15864529
   PubMed Web of Science ®Google Scholar
• Pietraszek A Gregersen S Hermansen K Acute effects of dietary fat on inflammatory markers and gene expression in first-degree relatives of type 2 diabetes patients Rev Diabet Stud 2011 8 4 477 489 22580729
   PubMedGoogle Scholar
• Arkan MC Hevener AL Greten FR IKK-beta links inflammation to obesity-induced insulin resistance Nat Med 2005 11 2 191 198 15685170
   PubMed Web of Science ®Google Scholar
• Reymond P Farmer EE Jasmonate and salicylate as global signals for defense gene expression Curr Opin Plant Biol 1998 1 5 404 411 10066616
   PubMed Web of Science ®Google Scholar
• Ebstein W Zur therapie des Diabetes mellitus, insbesondere über die Anwendung des salicylsauren Natron bei demselben Berliner Klinische Wochenschrift 1876 13 4 German
   Google Scholar
• Kim JK Kim YJ Fillmore JJ Prevention of fat-induced insulin resistance by salicylate J Clin Invest 2001 108 3 437 446 11489937
   PubMed Web of Science ®Google Scholar
• Fleischman A Shoelson SE Bernier R Goldfine AB Salsalate improves glycemia and inflammatory parameters in obese young adults Diabetes Care 2008 31 2 289 294 17959861
   PubMed Web of Science ®Google Scholar
• Goldfine AB Conlin PR Halperin F A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance Diabetologia 2013 56 4 714 723 23370525
   PubMed Web of Science ®Google Scholar
• Goldfine AB Fonseca V Jablonski KA The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial Ann Intern Med 2010 152 6 346 357 20231565
   PubMed Web of Science ®Google Scholar
• Kopp E Ghosh S Inhibition of NF-kappa B by sodium salicylate and aspirin Science 1994 265 5174 956 959 8052854
   PubMed Web of Science ®Google Scholar
• Hundal RS Petersen KF Mayerson AB Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes J Clin Invest 2002 109 10 1321 1326 12021247
   PubMed Web of Science ®Google Scholar
• Faghihimani E Aminorroaya A Rezvanian H Adibi P Ismail-Beigi F Amini M Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes Acta Diabetol 2013 50 4 537 543 21938543
   PubMed Web of Science ®Google Scholar
• Goto Y Suzuki K Ono T Sasaki M Toyota T Development of diabetes in the non-obese NIDDM rat (GK rat) Adv Exp Med Biol 1988 246 29 31 3074659
   PubMedGoogle Scholar
• Portha B Giroix MH Tourrel-Cuzin C Le-Stunff H Movassat J The GK rat: a prototype for the study of non-overweight type 2 diabetes Methods Mol Biol 2012 933 125 159 22893405
   PubMedGoogle Scholar
• Nie J Xue B Sukumaran S Jusko WJ DuBois DC Almon RR Differential muscle gene expression as a function of disease progression in Goto-Kakizaki diabetic rats Mol Cell Endocrinol 2011 338 1–2 10 17 21356272
   PubMed Web of Science ®Google Scholar
• Almon RR DuBois DC Lai W Xue B Nie J Jusko WJ Gene expression analysis of hepatic roles in cause and development of diabetes in Goto-Kakizaki rats J Endocrinol 2009 200 3 331 346 19074471
   PubMed Web of Science ®Google Scholar
• Xue B Sukumaran S Nie J Jusko WJ DuBois DC Almon RR Adipose tissue deficiency and chronic inflammation in diabetic Goto-Kakizaki rats PLoS One 2011 6 2 e17386 21364767
   PubMed Web of Science ®Google Scholar
• Cao Y DuBois DC Sun H Almon RR Jusko WJ Modeling diabetes disease progression and salsalate intervention in Goto-Kakizaki rats J Pharmacol Exp Ther 2011 339 3 896 904 21903749
   PubMed Web of Science ®Google Scholar
• Egger G Liang G Aparicio A Jones PA Epigenetics in human disease and prospects for epigenetic therapy Nature 2004 429 6990 457 463 15164071
   PubMed Web of Science ®Google Scholar
• Ling C Groop L Epigenetics: a molecular link between environmental factors and type 2 diabetes Diabetes 2009 58 12 2718 2725 19940235
   PubMed Web of Science ®Google Scholar
• Mofredj A Howaizi M Grasset D Diabetes mellitus during interferon therapy for chronic viral hepatitis Dig Dis Sci 2002 47 7 1649 1654 12141831
   PubMed Web of Science ®Google Scholar
• Li Z Soloski MJ Diehl AM Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease Hepatology 2005 42 4 880 885 16175608
   PubMed Web of Science ®Google Scholar
• Koska J Ortega E Bunt JC The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study Diabetologia 2009 52 3 385 393 19104769
   PubMed Web of Science ®Google Scholar
• Bruun JM Lihn AS Verdich C Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans Am J Physiol Endocrinol Metab 2003 285 3 E527 E533 12736161
   PubMed Web of Science ®Google Scholar
• Oana F Takeda H Hayakawa K Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin Metabolism 2005 54 8 995 1001 16092047
   PubMed Web of Science ®Google Scholar
• Kadowaki T Yamauchi T Adiponectin receptor signaling: a new layer to the current model Cell Metab 2011 13 2 123 124 21284979
   PubMed Web of Science ®Google Scholar
• Yamauchi T Kamon J Minokoshi Y Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nat Med 2002 8 11 1288 1295 12368907
   PubMed Web of Science ®Google Scholar
• Kahn BB Alquier T Carling D Hardie DG AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism Cell Metab 2005 1 1 15 25 16054041
   PubMed Web of Science ®Google Scholar